Effects of silybum marianum on patients with chronic hepatitis C

Journal of Research in Medical Sciences

Volumn 16, Issue 3, 2011, Pages 287-290

  Kalantari, Hamid ^a   Shahshahan, Zahra ^a   Hejazi, Sayed Mehdi ^b   Ghafghazi, Taghi ^b   Sebghatolahi, Vahid ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis C Virus (HCV); Quality of life; Serum Aminotransferases

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HYALURONIC ACID; SILYMARIN; VIRUS RNA;

ADOLESCENT; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; QUALITY OF LIFE; SCHOOL CHILD; SILYBUM MARIANUM;

EID: 79955517833     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kalantari H, Kazemi F, Minakari M. Efficacy of triple therapy with interferon alpha-2b, ribavirin and amantadine in the treatment of naïve patients with chronic hepatitis C. J Res Med Sci 2007; 12(4): 178-85.
2. Kalantari H, Rad N. Efficacy of Interferon alpha-2b with or without Ribavirin in thalassemia major patients with chronic hepatitis C virus infection: a randomized, doubleblind, controlled, parallel group trial. J Res Med Sci 2010; 15(6): 310-6.
3. Luper S. A review of plants used in the treatment of liver disease: part 1. Altern Med Rev 1998; 3(6): 410-21.
4. Mayer KE, Myers RP, Lee SS. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat 2005; 12(6): 559-67.
5. Salmi HA, Sarna S. Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study. Scand J Gastroenterol 1982; 17(4): 517-21.
6. Tanamly MD, Tadros F, Labeeb S, Makld H, Shehata M, Mikhail N, et al. Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Dig Liver Dis 2004; 36(11): 752-9.
7. Gordon A, Hobbs DA, Bowden DS, Bailey MJ, Mitchell J, Francis AJ, et al. Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C. J Gastroenterol Hepatol 2006; 21(1 Pt 2): 275-80.
8. Buzzelli G, Moscarella S, Giusti A, Duchini A, Marena C, Lampertico M. A pilot study on the liver protective effect of silybinphosphatiylcholine Complex (Idb1016) in chronic active hepatitis. Int J Clin Pharmacol Ther Toxicol 1993; 31(9): 456-60.
9. Johansen JS, Christoffersen P, Møller S, Price PA, Henriksen JH, Garbarsch C, et al. Serum YKL-40 is increased in patients with hepatic fibrosis. J Hepatol 2000; 32(6): 911-20.
10. Guéchot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42(4): 558-63.
11. Montazeri A, Goshtasebi A, Vahdaninia M, Gandek B. The Short Form Health Survey (SF-36): translation and validation study of the Iranian version. Qual Life Res 2005; 14(3): 875-82.
12. Mira L, Silva M, Manso CF. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem Pharmacol 1994; 48(4): 753-9.
13. Wagoner J, Negash A, Kane OJ, Martinez LE, Nahmias Y, Bourne N, et al. Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology 2010; 51(6): 1912-21.
14. Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology 2003; 37(5): 972-4.
15. Martines G, Piva M, Copponi V, Cagnetta G. Silymarin in pregnancy and during hormonal contraceptive treatment. Blood chemistry and ultrastructural findings in the experimental model. Arch Sci Med (Torino) 1979; 136(3): 443-54.(Italian).
16. Geier J, Fuchs T, Wahl R. Anaphylactic shock due to an extract of Silybum marianum in a patient with immediatetype allergy to kiwi fruit. Allergologie 1990; 13(10): 387-8.
17. Mironets VI, Krasovskaia EA, Polishchuk II. A case of urticaria during carsil treatment. Vrachebnoe Delo 1990; (7): 86-7. (Russian).
18. An adverse reaction to the herbal medication milk thistle (Silybum marianum). Adverse Drug Reactions Advisory Committee. Med J Aust 1999; 170(5): 218-9.